ReviewExpert review of respiratory medicine2016
Drivers of MERS-CoV transmission: what do we know?
Review in Expert review of respiratory medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review.Travel medicine and infectious diseasePooled it
- A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Travel medicine and infectious diseasePooled it
- Operational zoonotic containment of Middle East respiratory syndrome coronavirus in Saudi Arabia: An implementation-oriented One Health genomic framework.Veterinary world · 2026Review
- Article
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is Not Circulating Among Hajj Pilgrims.Journal of epidemiology and global health · 2023Article
- What is the burden of asymptomatic coronavirus infections?New microbes and new infections · 2023Article
- Understanding the Role of Environmental Transmission on COVID-19 Herd Immunity and Invasion Potential.Bulletin of mathematical biology · 2022Article
- Estimation of the Reproductive Number Trend of the Novel Coronavirus "COVID-19" in Southern Iran from July to November 2020.Iranian journal of medical sciences · 2022Article
- Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses: A "Big Events" Perspective.International journal of environmental research and public health · 2022Article
- A cross-sectional study of epidemiological determinants for Covid-19 infection among nurses of a tertiary care hospital.Journal of education and health promotion · 2022Article
- Determining the correlation between comorbidities and MERS-CoV mortality in Saudi Arabia.Journal of Taibah University Medical Sciences · 2021Article
- Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.Human vaccines & immunotherapeutics · 2021Article
- Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19.Human vaccines & immunotherapeutics · 2020Review
- The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.Journal of virology · 2020Article
- Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.The Lancet. Infectious diseases · 2020Article
- Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020Article
- Winter Is Coming: A Southern Hemisphere Perspective of the Environmental Drivers of SARS-CoV-2 and the Potential Seasonality of COVID-19.International journal of environmental research and public health · 2020Review
- Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus.Seminars in respiratory and critical care medicine · 2020Review
- The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act.Journal of infection and public health · 2020Review
- COVID-19 R0: Magic number or conundrum?Infectious disease reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Middle East Respiratory Syndrome coronavirus (MERS-CoV) emerged in 2012 has since resulted in sporadic cases, intra-familial transmission and major outbreaks in healthcare settings. The clinical picture of MERS-CoV includes asymptomatic infections, mild or moderately symptomatic cases and fatal disease. Transmissions of MERS-CoV within healthcare settings are facilitated by overcrowding, poor compliance with basic infection control measures, unrecognized infections, the superspreaders phenomenon and poor triage systems. The actual contributing factors to the spread of MERS-CoV are yet to be systematically studied, but data to date suggest viral, host and environmental factors play a major role. Here, we summarize the known factors for the diverse transmission of MERS-CoV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.